Pharming (PHAR) Inventory Average (2021 - 2026)

Pharming's Inventory Average history runs 6 years deep, the most recent figure standing at $64.7 million for Q1 2026.

• Quarterly Inventory Average rose 12.52% year-over-year to $64.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.7 million (up 12.52% YoY) and the FY2025 annual result came in at $60.3 million, up 134.46% from the prior year.
• Inventory Average was $64.7 million for Q1 2026 at Pharming, down from $66.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $66.0 million in Q4 2025 and bottomed at -$968747.0 in Q4 2022.
• A 5-year average of $43.1 million and a median of $53.2 million in 2023 frame the typical range for Inventory Average.
• Peak annual rise in Inventory Average reached 69946.55% in 2022, while the deepest fall reached 107.71% in 2022.
• Pharming's Inventory Average stood at -$968747.0 in 2022, then jumped by 2637.45% to $24.6 million in 2023, then jumped by 139.92% to $59.0 million in 2024, then rose by 11.94% to $66.0 million in 2025, then slipped by 1.94% to $64.7 million in 2026.
• Business Quant data shows PHAR's Inventory Average at $64.7 million in Q1 2026, $66.0 million in Q4 2025, and $65.4 million in Q3 2025.